Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry

被引：0
|
作者：
Hyun J. Kim [1 ]
Jeremy M. Weber [2 ]
Megan L. Neely [2 ]
Amy Hajari Case [3 ]
Aiham H. Jbeli [4 ]
Peide Li [1 ]
Amy L. Olson [5 ]
Laurie D. Snyder [5 ]
机构：
[1] University of Minnesota,
[2] Duke Clinical Research Institute,undefined
[3] Duke University Medical Center,undefined
[4] Piedmont Healthcare,undefined
[5] Boehringer Ingelheim Pharmaceuticals,undefined
[6] Inc,undefined
来源：
Lung | 2025年 / 203卷 / 1期
关键词：
Interstitial lung diseases; Mortality; Prognosis; Observational study;
D O I：
10.1007/s00408-025-00797-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Hospital-Based Resource Use and Costs Among Patients With Idiopathic Pulmonary Fibrosis Enrolled in the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry
    Fan, Yanni
    Bender, Shaun D.
    Conoscenti, Craig S.
    Davidson-Ray, Linda
    Cowper, Patricia A.
    Palmer, Scott M.
    de Andrade, Joao A.
    CHEST, 2020, 157 (06) : 1522 - 1530
  • [42] Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
    Jamie L. Todd
    Richard Vinisko
    Yi Liu
    Megan L. Neely
    Robert Overton
    Kevin R. Flaherty
    Imre Noth
    L. Kristin Newby
    Joseph A. Lasky
    Mitchell A. Olman
    Christian Hesslinger
    Thomas B. Leonard
    Scott M. Palmer
    John A. Belperio
    BMC Pulmonary Medicine, 20
  • [43] Circulating Urokinase-Type Plasminogen Activator Receptor Protein Highly Correlates With the Severity of Idiopathic Pulmonary Fibrosis (IPF): Data From the IPF-PRO Registry
    Todd, J. L.
    Mulder, H.
    Neely, M. L.
    Belperio, J. A.
    Lasky, J. A.
    Luckhardt, T. R.
    Palmer, S. M.
    Hesslinger, C.
    Schlange, T.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort
    Todd, Jamie L.
    Vinisko, Richard
    Liu, Yi
    Neely, Megan L.
    Overton, Robert
    Flaherty, Kevin R.
    Noth, Imre
    Newby, L. Kristin
    Lasky, Joseph A.
    Olman, Mitchell A.
    Hesslinger, Christian
    Leonard, Thomas B.
    Palmer, Scott M.
    Belperio, John A.
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [45] Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis A Cross-Sectional Analysis of the IPF-PRO Registry
    O'Brien, Emily C.
    Hellkamp, Anne S.
    Neely, Megan L.
    Swaminathan, Aparna
    Bender, Shaun
    Snyder, Laurie D.
    Culver, Daniel A.
    Conoscenti, Craig S.
    Todd, Jamie L.
    Palmer, Scott M.
    Leonard, Thomas B.
    CHEST, 2020, 157 (05) : 1188 - 1198
  • [46] SAFETY OF NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): LONG-TERM GLOBAL PHARMACOVIGILANCE DATA
    Lasky, Joseph
    Criner, Gerard
    Lazarus, Howard
    Kohlbrenner, Veronika
    Bender, Shaun
    Richeldi, Luca
    CHEST, 2019, 156 (04) : 1011A - 1012A
  • [47] Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
    Gao, Jing
    Kalafatis, Dimitrios
    Carlson, Lisa
    Li, Chuan-Xing
    Pesonen, Ida
    Skold, Magnus
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [49] The long-term safety of pirfenidone (PFD) in patients with idiopathic pulmonary fibrosis (IPF)
    Valeyre, Dominique
    Albera, Carlo
    Bradford, Williamson
    Costabel, Ulrich
    King, Talmadge
    Noble, Paul
    Sahn, Steven
    du Bois, Roland
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [50] Associations Between Circulating MicroRNAs and Clinical Outcomes in Patients with IPF: Data from the IPF-PRO Registry
    Luckhardt, T.
    Neely, M. L.
    Mulder, H.
    Belperio, J. A.
    Ramaswamy, M.
    Salisbury, M. L.
    Hesslinger, C.
    Palmer, S. M.
    Todd, J. L.
    Leonard, T. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345